EUCTR2018-002984-24-DE进行中（未招募）1 期
Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients from 6 Months to Less Than 2 Years Old - SCOB2 (Study Cystadrops® Ophthalmic for Patients Below 2 years)
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients must meet all inclusion criteria to be eligible for study participation.
- •1.Patient aged from 6 months to less than 2 years old
- •2.Cystinosis diagnosed patients confirmed by the physician and with presence of corneal cystine crystal deposits assessed during ophthalmic examination
- •3.Evidence of a signed and dated informed consent document indicating that parents/ legally acceptable representatives had been informed of all pertinent aspects of the study (if required by regulation)
- •4.Parents/ legally acceptable representatives who are willing to comply with regular visits and ophthalmic exams
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients will not be eligible for study participation if they meet any of the exclusion criteria, or will be discontinued at the discretion of the Investigator in consultation with the medical monitor if they develop any of the exclusion criteria during the study.
- •1.Contraindications to any of the Cystadrops® components
- •2.Participation in another ophthalmic investigational study or intent to participate during the course of the study
- •3.Any medical condition that would, in the opinion of the Investigator, interfere with the evaluation of the study objectives
研究者
相似试验
进行中（未招募）
1 期
Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients from 6 Months to Less Than 2 Years OldEUCTR2018-002984-24-BERecordati Rare Diseases5
进行中（未招募）
1 期
Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients from 6 Months to Less Than 2 Years Oldephropatic Cystinosis patients with corneal cystine crystal depositsMedDRA version: 20.0 Level: LLT Classification code 10071112 Term: Nephropathic cystinosis System Organ Class: 100000004850EUCTR2018-002984-24-FRRecordati Rare Diseases5
进行中（未招募）
1 期
Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the hostPulmonary Mycobacterium tuberculosis infectionMedDRA version: 20.0Level: PTClassification code 10037440Term: Pulmonary tuberculosisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-002514-40-ITISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI30
已完成
3 期
Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)CystinosisNCT04125927Recordati Rare Diseases5
尚未招募
3 期
Assessment of praziquantel medication for children living in areas where schistosomiasis is common in Bahia and SergipeRBR-86kcy37Instituto Gonçalo Moniz (IGM) - Fundação Oswaldo Cruz (Fiocruz-BA)